Professor Zdravko Lackovic, MD, PhD
Laboratory of Molecular Neuropharmacology, Department of Pharmacology & Croatian Brain Research Institute, University of Zagreb Medical School, Salata 11,10 000 Zagreb, Croatia
Place and date of birth Pitomaca, Croatia, April 29, 1947
Degrees and professional qualifications:
1971 Medical Doctor (MD), University of Zagreb Medical School
1975 Master of Biological Science (Mr.Sc), Postgraduate Study for Scientific Perfection in Biology, University of Zagreb.
1976 Doctor of Medical Science (PhD); University of Zagreb Medical School
1979 Associate Professor (“Docent”) in Pharmacology, University of Zagreb Medical School
1984 Professor in Pharmacology, University of Zagreb Medical School
1996 Professor in Pharmacology (reelected, permanent position) University of Zagreb Medical School
1979-1981 Visiting Scientist (Fogarty Fellowship), Laboratory of Preclinical Pharmacology, National Institute for Mental Health, Washington DC, USA
1995-1996 (sabbatical) Established Visting Scientist (S.Juselius Foundation) at Department of Biology, Abo Akademi University, Turku, Finland
Membership of learned societies etc.
Croatian Pharmacological Society (President 1998-2001),
Society for Neuroscience – SFN (USA)
Academy of Medical Sciences of Croatia – regular member
Current substantive appointment
Professor of Pharmacology, University of Zagreb Medical School
Deputy Dean for PhD Programme and Director of PhD Programme “Biomedicine and Health Sciences” University of Zagreb Medical School
Other current appointments
President, ORPHEUS (ORganisation of PhD Education in Biomedicine and Health Sciences in the EUropean System) (2007-)
EC member, AMSE – Association of Medical Schools in Europe (2004 -)
Other recent appointments
1984-1991 Vice Dean for Science, Medical School of Zagreb
1988-1990 President of the Board for Scientific Cooperation with Western Countries and European Community, SIZ for Science of Croatia
1993-1995 Expert in COST Ad hoc Working Party for Neuroscience Coordination in Europe (European Community)
2002-2005 Member of Bioethical Committee of the Government of Croatia
2006-present Council of the Croatian Agency for Science and Higher Education
Other professional experiences
More than 20 invited lectures on international congresses or distinguished foreign universities
Author, co-author or editor of several pharmacology books including Croatian textbook “Medicinska farmakologija” (medicinska Naklada, Zagreb 2001.) Past or current member of editorial board of several scientific journal (Lijeènièki vjesnik, Croatian Medical Journal, currently Medicus and Pharmacologyonline( ISSN 1827-8620 – www. pharmacologyonline.unisa.it)
Mentorship: 12 MD Thesis, 8 Mr Sc Thesis (magisterium of science) and 4 PhD Thesis
Founder of Laboratory of Molecular Neuropharmacology
Organizer of the First Yugoslav Conference “Neurotransmitters in Health and Disease”, Zagreb 1986
Founder and organizer of PHD Programme of University of Zagreb Medical school “Biomedicine and Health Sciences”
Organizer (president of the Organizing Committee): Second Croatian Congress of Pharmacology with International Participation (Zagreb 2001)
Member of permanent Kuratorium (Board of Trustees) of Pula Neuropsychiatric Congress
Organizer (president of the Organizing and Scientific Committee): the First European Conference on Harmonization of PhD Programes in Biomedicine and Health Sciences, Zagreb 2004
Organizer (president of Organizing and Scientific Committee): the Second European Conference on Harmonization of PhD Programes in Biomedicine and Health Sciences, Zagreb 2005
Bulat M, Lackovic Z, Jakupcevic M and Damjanov I. 5-Hydroxyindoleacetic acid in the lumbar fluid: a specific indicator of spinal cord injury. Science 1974; 185: 527-528.
Lackovic Z, Parenti M, Neff N.H. Simultaneous determination of femtomole quantities of 5-hydroxyindoleacetic acid in brain using HPLC with electrochemical detection. Europ J Pharmacol 1981; 69: 347-352.
Lackovic Z, Relja M, Neff N.H. Catabolism of endogenous dopamine in peripheral tissues: is there an independent role for dopamine in peripheral neurotransmission. J Neurochem 1982; 38; 1453-1458.
Lackovic Z, Neff N.H. Evidence that dopamine is a neurotransmitter in peripheral tissues. Life Sci, 1983; 32: 1665-1674.
Lackovic Z, Relja M. Evidence for widely distributed peripheral dopaminergic system. Fed Proc, 1983; 42: 3000-3004.
Lackovic Z, Jakupcevic M, Bunarevic A, Damjanov I, Relja M, Kostovic I, Serotonin and norepinephrine in the spinal cord of man, Brain Res 1988; 443: 199-203.
Lackovic Z, Salkoviæ M, Kuci Z, Relja M, Effect of long-lasting diabetes mellitus on rat and human brain monoamines, J Neurochem 1990; 54: 143-147.
Salkovic M, Lackovic Z: Brain D1 dopamine receptor in alloxan-induced diabetes. Diabetes 1992; 41: 1119-1121.
Trkulja V, Lackovic Z. Involvement of muscarinic receptors in the control of female puberty in the rat. Eur J Pharmacol. 1996;297:93-6
Trkulja V, Crljen-Manestar V, Banfic H, Lackovic Z. Involvement of the peripheral cholinergic muscarinic system in the compensatory ovarian hypertrophy in the rat. Exp Biol Med 2004; 229:793-805
Bach-Rojecky L, Relja M, Lackovic Z. Botulinum toxin type A in experimental neuropathic pain. J Neural Transm. 2005;112:215-217.
Bach-Rojecky L, Lackovic Z. Central origin of antinociceptiver activity of botulinum toxin type A. Pharmacol Biochem Behav. 2009 ;94(2):234-8
Bach-Rojecky L, Salković-Petrisić M, Lacković Z. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection. Eur J Pharmacol. 2010 May 10;633(1-3):10-4. Epub 2010 Feb 1.
Matak I, Bach-Rojecky L, Filipović B, Lacković Z. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience. 2011 Jul 14;186:201-7. Epub 2011 Apr 20.
Filipović B, Matak I, Bach-Rojecky L, Lacković Z. Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy. PLoS One. 2012;7(1):e29803. Epub 2012 Jan 4. PMID: 22238656
Matak I, Riederer P, Lacković Z. Botulinum toxin’s axonal transport from periphery to the spinal cord. Neurochem Int. 2012 May 8. [Epub ahead of print] PMID: 22580329
Drinovac V, Bach-Rojecky L, Matak I, Lacković Z. Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A. Neuropharmacology. 2013;70:331-7
Matak, I., Rossetto, O., Lacković, Z. 2014 Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons. Pain 155, 1516-1526.
Matak, I., Lacković, Z. 2014 Botulinum toxin A, brain and pain. Progress in Neurobiology. 119-120, 39-59.
He became ORPHEUS Executive Committee member February 9, 2007. By decision of Zagreb City Office for General Administration January 26, 2012, the mandate of Zdravko Lackovic, as legal representative of ORPHEUS, will finish in 2014. Decision was accepted by General Assembly, Bergen 2012.
At the closing ceremony at Lausanne 2014 Conference Professor Zdravko Lackovic was nominated to be elected Honorary Member of ORPHEUS. On behalf of 12 Universities, ORPEHUS members, and Professor David Gordon president of WFME, the proposal was presented by professor Gull Gunner Akdoğan by reading part of the email send by professor David Gordon: “I …support this in the strongest possible terms. I have been associated with ORPHEUS from its earliest days, I was one of those responsible for the foundation of ORPHEUS, and I was the first Vice-President. It is clear to me that without Professor Lacković’s vision, foresight and energy, ORPHEUS would never have come into existence and the excellent work that ORPHEUS has done over the last decade would never have happened.” … The proposal was accepted unanimously with applause.